35 results
P
1611 patients
I/C
Abdominal approaches (AA), Perineal approaches (PA), AA vs PA
O
Recurrence at the last available follow-up, Factors associated with recurrence and function
P
CD152 polymorphism
I/C
rs231775, rs3087243, rs5742909, AA vs. GG, AA vs. AG, GG vs. AA, GA vs. GG, AA vs. GG + GA, GG vs. AA + AG, A vs. G, GA vs. GG
O
decreased cervical cancer risk, elevated disease onset
P
older adults
I/C
alpha angle (AA), radiographic hip osteoarthritis (OA)
O
total hip replacement
P
children
I/C
Alvarado score (AS), acute appendicitis (AA)
O
diagnostic accuracy
P
patients with advanced prostate cancer
I/C
abiraterone acetate (AA), placebo ± steroid
O
hypokalemia, fluid retention, hypertension, cardiac events
P
17,746 cases, 21,808 controls
I/C
miR-26a-1 rs7372209 polymorphism, miR-423 rs6505162 polymorphism, homozygote comparison, recessive model, CA versus CC, AA + CA versus CC, AA versus CA + CC, A versus C
O
susceptibility to overall cancer
P
East Asian population
I/C
ALDH2 polymorphism, GG versus GA/AA
O
cardiometabolic risk factors, including hypertension, fasting blood glucose, triglycerides, low-density lipoprotein cholesterol, and body mass index
P
adult patients with antiplatelet-associated intracerebral hemorrhage (AA-ICH)
I/C
desmopressin, controls
O
hematoma expansion (HE), thrombotic complications, neurologic outcome (mRS ≥ 4)
P
patients with androgenetic alopecia (AGA) and alopecia areata (AA)
I/C
platelet-rich plasma (PRP) injections, saline injections, local steroid injections, other comparators
O
hair density, hair regrowth
P
individuals with CC genotype, individuals with C allele
I/C
PD-L1 rs2890658 polymorphism, individuals with AA genotype, individuals with A allele
O
increased risk of developing NSCLC